Apimeds Pharmaceuticals US, Inc. files current report with SEC

Apimeds Pharmaceuticals US, Inc. filed an 8-K covering SEC Item 3.03 and charter, bylaw or fiscal-year changes. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.